PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsClobetasol propionate
Clobetasol propionate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
126 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PsoriasisD011565EFO_0000676L4099815444
Vulvar lichen sclerosusD007724—N90.4—431411
Bullous pemphigoidD010391EFO_0007187L12—212—5
Alopecia areataD000506EFO_0004192L631—11—3
Contact dermatitisD003877—L251——1—2
Occupational dermatitisD009783—————1—1
OsteoporosisD010024HP_0000939M81.0———1—1
Hypertrophic cicatrixD017439—L91.0———1—1
Photosensitivity disordersD010787HP_0000992L57.1———1—1
AlopeciaD000505HP_0002293L64———1—1
Show 1 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Oral lichen planusD017676———62—310
Graft vs host diseaseD006086—D89.81—11——2
Lichen sclerosus et atrophicusD018459—L90.0—11——2
CataractD002386HP_0000518H26.9——2——2
Oral manifestationsD009912————1——1
Rheumatoid arthritisD001172EFO_0000685M06.9——1——1
Seborrheic dermatitisD012628HP_0001051L21——1——1
Acne keloidD000153—L73.0——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atopic dermatitisD003876EFO_0000274L2031——14
PhlebitisD010689EFO_1001395I8011———1
Stevens-johnson syndromeD013262EFO_0004276L51.111———1
Herpes labialisD006560EFO_1001347B00.1—1———1
Renal cell carcinomaD002292EFO_0000376——1———1
Colorectal neoplasmsD015179———1———1
AdenocarcinomaD000230———1———1
HemorrhoidsD006484EFO_0009552K64—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———4———37
VasoconstrictionD014661——1————1
Skin and connective tissue diseasesD017437——1————1
Oral ulcerD019226HP_0000155—1————1
Connective tissue diseasesD003240EFO_1001986M351————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InflammationD007249MP_0001845—————11
Drug hypersensitivity syndromeD063926EFO_1002004D72.12————11
EczemaD004485HP_0000964L30.9————11
Low-level light therapyD028022——————11
Lyme diseaseD008193—A69.2————11
Precancerous conditionsD011230——————11
Skin diseasesD012871—L00-L99————11
LentigoD007911—L81.4————11
HyperpigmentationD017495HP_0000953—————11
Adrenal insufficiencyD000309——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,269 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,218 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use